The Fishers,
Indiana-based CDMO announces new investment for growth into
second building, enhanced manufacturing capabilities
FISHERS,
Ind., July 15, 2024 /PRNewswire/ -- INCOG
BioPharma Services, a contract development and manufacturing
organization (CDMO) specializing in sterile injectable
biopharmaceuticals, is excited to announce a new investment to
expand its manufacturing capabilities. The expansion includes the
construction of a second 100,000-square-foot building on its
campus, set to break ground in August. This will increase the
company's commercial-scale device assembly capacity in support of
autoinjectors, pens, wearable injectors, and syringe accessorizing,
while also adding new labeling and final packaging
capabilities.
The second building will further enable INCOG to offer
comprehensive, end-to-end solutions from filling to device assembly
and final packaging, streamlining the process and simplifying the
supply chain solution for its global biopharma customers.
"We are excited about this new investment and the opportunities
it brings," said Cory Lewis, CEO and
Founder of INCOG. "Our customers will have access to a suite of
solutions from filling through final packaging. This supply chain
integration is essential in accelerating a drug product to
commercial launch, and even more important in today's constrained
markets as the need for sterile injectable products is quickly
growing to address challenging diseases and improve healthcare
outcomes. The hard work and expertise of the team we have built at
INCOG has allowed us to accelerate investments and address the
immediate needs of the global biopharma industry."
This expansion will create over 100 additional high-paying jobs,
further establishing Fishers, and
the state of Indiana, as a global
leader in biopharmaceutical innovation and manufacturing. The
Indiana Economic Development Corporation cited research showing
that the state is the largest exporter of pharmaceutical products
in the continental United States.
At the end of 2023, Indiana's Life
Science sector had over 3,000 companies, employing 67,000 people
and contributing $95 billion to the
state's economy. The IEDC and the City of
Fishers played a pivotal role in supporting INCOG to obtain
the necessary funding for the expansion.
"We are proud to contribute to the social and economic growth of
Fishers, by creating new jobs and
fostering a vibrant life science community," added Lewis. "The city
and IEDC have served as an extension of our team. It's exciting to
bring current and prospective clients to our facility so they can
experience the growing community where we do business."
"We are incredibly proud to witness INCOG's growth and expansion
into a second building," said Fishers Mayor Scott
Fadness. "This expansion reinforces Fishers as a leading hub for life sciences and
biopharma manufacturing. INCOG has played a significant role in
building the industry cluster in Fishers, and we look forward to celebrating
their future successes."
This project comes on the heels of current work to commission
and install a second high-speed syringe and cartridge filling line,
along with supporting automated visual inspection equipment. The
new filling line complements INCOG's existing multi-use filling
line, bringing the site's filling capacity to 140 million units per
year. The automated visual inspection and autoinjector assembly
capabilities are available now, with the additional syringe filling
capacity coming online in Q2 2025. These enhancements further
enable INCOG to meet the growing demand for biopharmaceutical
solutions that utilize pre-filled syringes and autoinjector
delivery mechanisms.
About INCOG BioPharma Services
Founded by a team of industry veterans, INCOG BioPharma Services
offers manufacturing services to biopharmaceutical companies at all
stages of development. Our experienced team, best-in-class
processes, and state-of-the-art equipment combine to provide
meaningful results and stand-out customer experiences for our
customers and partners. INCOG is an FDA-approved facility
specializing in sterile injectable biopharmaceuticals, producing
both clinical and commercial-stage products. The company's service
offering includes filling drug products into syringes, cartridges,
and vials. INCOG also offers support services, including
formulation scale-up, analytical development, stability testing and
storage, and auto-injector device assembly. We go above and beyond
to understand your requirements, meet your needs, and foster a
truly collaborative partnership.
For additional information about INCOG BioPharma Services,
please contact us
at info@incogbiopharmaservices.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/incog-biopharma-accelerates-expansion-plans-302196830.html
SOURCE INCOG BioPharma